Literature DB >> 22585405

Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.

Anneliese O Speak1, Nicholas Platt, Mariolina Salio, Danielle te Vruchte, David A Smith, Dawn Shepherd, Natacha Veerapen, Gurdyal S Besra, Nicole M Yanjanin, Louise Simmons, Jackie Imrie, James E Wraith, Robin H Lachmann, Ralf Hartung, Heiko Runz, Eugen Mengel, Michael Beck, Christian J Hendriksz, Forbes D Porter, Vincenzo Cerundolo, Frances M Platt.   

Abstract

Invariant natural killer T (iNKT) cells are a specialised subset of T cells that are restricted to the MHC class I like molecule, CD1d. The ligands for iNKT cells are lipids, with the canonical superagonist being α-galactosylceramide, a non-mammalian glycosphingolipid. Trafficking of CD1d through the lysosome is required for the development of murine iNKT cells. Niemann-Pick type C (NPC) disease is a lysosomal storage disorder caused by dysfunction in either of two lysosomal proteins, NPC1 or NPC2, resulting in the storage of multiple lipids, including glycosphingolipids. In the NPC1 mouse model, iNKT cells are virtually undetectable, which is likely due to the inability of CD1d to be loaded with the selecting ligand due to defective lysosomal function and/or CD1d trafficking. However, in this study we have found that in NPC1 patients iNKT cells are present at normal frequencies, with no phenotypic or functional differences. In addi-tion, antigen-presenting cells derived from NPC1 patients are functionally competent to present several different CD1d/iNKT-cell ligands. This further supports the hypothesis that there are different trafficking requirements for the development of murine and human iNKT cells, and a functional lysosomal/late-endosomal compartment is not required for human iNKT-cell development.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585405      PMCID: PMC3461304          DOI: 10.1002/eji.201141821

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells.

Authors:  Alexandre Darmoise; Susann Teneberg; Lauriane Bouzonville; Roscoe O Brady; Michael Beck; Stefan H E Kaufmann; Florian Winau
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

Review 2.  Control points in NKT-cell development.

Authors:  Dale I Godfrey; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2007-07       Impact factor: 53.106

3.  Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients.

Authors:  Andrea Balreira; Maria F Macedo; Cristina Girão; Lorena G Rodrigues; João P Oliveira; Maria Clara Sá Miranda; Fernando A Arosa
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

Review 4.  Diversification of CD1 proteins: sampling the lipid content of different cellular compartments.

Authors:  V Briken; D B Moody; S A Porcelli
Journal:  Semin Immunol       Date:  2000-12       Impact factor: 11.130

5.  Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.

Authors:  Jens Schümann; Federica Facciotti; Luigi Panza; Mario Michieletti; Federica Compostella; Anthony Collmann; Lucia Mori; Gennaro De Libero
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

6.  Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C.

Authors:  Robin H Lachmann; Danielle te Vruchte; Emyr Lloyd-Evans; Gabriele Reinkensmeier; Daniel J Sillence; Luisa Fernandez-Guillen; Raymond A Dwek; Terry D Butters; Timothy M Cox; Frances M Platt
Journal:  Neurobiol Dis       Date:  2004-08       Impact factor: 5.996

7.  Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.

Authors:  Carlos J Montoya; David Pollard; Jeffrey Martinson; Kumud Kumari; Clive Wasserfall; Candice B Mulder; Maria T Rugeles; Mark A Atkinson; Alan L Landay; S Brian Wilson
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

8.  Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development.

Authors:  Manuela Cernadas; Masahiko Sugita; Nicole van der Wel; Xiaochun Cao; Jenny E Gumperz; Sergei Maltsev; Gurdyal S Besra; Samuel M Behar; Peter J Peters; Michael B Brenner
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

9.  Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

Authors:  Stephan D Gadola; Jonathan D Silk; Aruna Jeans; Petr A Illarionov; Mariolina Salio; Gurdyal S Besra; Raymond Dwek; Terry D Butters; Frances M Platt; Vincenzo Cerundolo
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

10.  Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.

Authors:  Emyr Lloyd-Evans; Anthony J Morgan; Xingxuan He; David A Smith; Elena Elliot-Smith; Daniel J Sillence; Grant C Churchill; Edward H Schuchman; Antony Galione; Frances M Platt
Journal:  Nat Med       Date:  2008-10-26       Impact factor: 53.440

View more
  10 in total

Review 1.  Emptying the stores: lysosomal diseases and therapeutic strategies.

Authors:  Frances M Platt
Journal:  Nat Rev Drug Discov       Date:  2017-11-17       Impact factor: 84.694

2.  Crohn's Disease in Niemann-Pick Disease Type C1: Caught in the Cross-Fire of Host-Microbial Interactions.

Authors:  Athena Cavounidis; Holm H Uhlig
Journal:  Dig Dis Sci       Date:  2018-04       Impact factor: 3.199

3.  Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin.

Authors:  Espen Melum; Xiaojun Jiang; Kristi D Baker; M Fatima Macedo; Jürgen Fritsch; C Marie Dowds; Jing Wang; Anne Pharo; Arthur Kaser; Corey Tan; Catia S Pereira; Samuel L Kelly; Jingjing Duan; Tom H Karlsen; Mark A Exley; Stefan Schütze; Dirk M Zajonc; Alfred H Merrill; Edward H Schuchman; Sebastian Zeissig; Richard S Blumberg
Journal:  Nat Immunol       Date:  2019-10-21       Impact factor: 25.606

Review 4.  Immune dysfunction in Niemann-Pick disease type C.

Authors:  Nick Platt; Annelise O Speak; Alexandria Colaco; James Gray; David A Smith; Ian M Williams; Kerri-Lee Wallom; Frances M Platt
Journal:  J Neurochem       Date:  2015-06-04       Impact factor: 5.372

Review 5.  From Lysosomal Storage Diseases to NKT Cell Activation and Back.

Authors:  Cátia S Pereira; Helena Ribeiro; M Fatima Macedo
Journal:  Int J Mol Sci       Date:  2017-02-25       Impact factor: 5.923

6.  Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.

Authors:  Catia S Pereira; Begoña Pérez-Cabezas; Helena Ribeiro; M Luz Maia; M Teresa Cardoso; Ana F Dias; Olga Azevedo; M Fatima Ferreira; Paula Garcia; Esmeralda Rodrigues; Paulo Castro-Chaves; Esmeralda Martins; Patricio Aguiar; Mercè Pineda; Yasmina Amraoui; Simona Fecarotta; Elisa Leão-Teles; Shenglou Deng; Paul B Savage; M Fatima Macedo
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 7.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

8.  Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition.

Authors:  Crina Paduraru; Jelena S Bezbradica; Amit Kunte; Robert Kelly; James A Shayman; Natacha Veerapen; Liam R Cox; Gurdyal S Besra; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

Review 9.  Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.

Authors:  Shweta Tiwary; Jay A Berzofsky; Masaki Terabe
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

Review 10.  Lyso-glycosphingolipids: presence and consequences.

Authors:  Marco van Eijk; Maria J Ferraz; Rolf G Boot; Johannes M F G Aerts
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.